Former Head of Johnson and Johnson Ukraine to Join Electromedical Technologies, Inc. Marketing Advisory Board
Constantin Kishkovski was formerly Head of The Representative Office in the
Constantin Kishkovski commented, “I look forward to working with
Commenting further, Mr. Kishkovski said, “As we find ourselves and communities shifting to a “New Normal” when it comes to daily life, more and more people will be looking towards telemedicine and treatments at home. There are millions of people who find themselves in lockdown and struggling with chronic pain and Opioid abuse. The WellnessPro® Plus is a logical choice for people, especially since it has been helping thousands of people relive their chronic pain and achieve a better quality of life without toxic side effects or drug interactions for years.”
Recently, the Company signed scientific collaborations for research with
Nonhuman preliminary studies that we are planning to start in near future and such applications are not related to our current product in any way and currently not cleared in the US.
For more information, visit https://electromedtech.com
Safe Harbor Statement:
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.